Progress on M cells-targeted oral vaccine delivery systems
10.12206/j.issn.2097-2024.202509037
- VernacularTitle:靶向M细胞的口服疫苗递送系统的研究进展
- Author:
Anze LIU
1
;
Yingxin DONG
1
;
Huan WANG
1
;
Ying LU
1
Author Information
1. School of Pharmacy, Naval Medical University, Shanghai 200433, China.
- Publication Type:Reviews
- Keywords:
oral vaccine;
microfold cell;
targeted delivery;
mucosal immunity
- From:
Journal of Pharmaceutical Practice and Service
2026;44(8):389-394
- CountryChina
- Language:Chinese
-
Abstract:
Oral vaccines, owing to their non-invasive nature, ease of administration, and ability to elicit both mucosal and systemic immune responses, represent a pivotal direction in vaccine development. Microfold cells (M cells), a specialized subset of immune-surveillance epithelial cells, though sparsely distributed, possess exceptional capacity for antigen uptake and transcytosis, rendering them a critical target for overcoming the bottlenecks of oral vaccine delivery. The morphological structure, antigen uptake mechanisms, and surface receptor characteristics of intestinal M cells were summarized in this paper. The multifaceted challenges currently impeding M cell-targeted oral delivery and recent advances in targeting strategies based on receptor–ligand specific recognition were analyzed. The design and application of delivery carriers tailored for M cell targeting were reviewed, which aimed to provide insights and guidance for future research and development of M cell-targeted mucosal delivery systems in the intestine.